Robotic assisted radical cystectomy versus open radical cystectomy: A review of what we do and don't know

Zeynep G. Gul, Andrew B. Katims, Jared S. Winoker, Peter Wiklund, Nikhil Waingankar, Reza Mehrazin

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Radical cystectomy (RC) is the gold standard treatment for muscle-invasive and high-risk, noninvasive bladder cancer. Since 2003, robot-assisted radical cystectomy (RARC) has been gaining popularity. Metanalyses show that the primary advantage of RARC is less blood loss and the primary advantage of open radical cystectomy (ORC) is shorter operative times. There do not appear to be significant differences in complications, cancer-related outcomes or survival between the two approaches. Cost analyses comparing RARC and ORC are complicated by the often-ill-defined distinction between the cost to the hospital versus the cost to payors. However, it is likely that for both hospitals and payors, RARC is cost effective at high-volume centers. It is feasible that in the future, increased experience with RARC will lead to improved outcomes and justify the use of RARC over ORC.

Original languageEnglish
Pages (from-to)2209-2215
Number of pages7
JournalTranslational Andrology and Urology
Volume10
Issue number5
DOIs
StatePublished - May 2021

Keywords

  • Cost analysis
  • Cystectomy
  • Randomized controlled trials (RCTs) as topic
  • Robotics
  • Treatment outcome

Fingerprint

Dive into the research topics of 'Robotic assisted radical cystectomy versus open radical cystectomy: A review of what we do and don't know'. Together they form a unique fingerprint.

Cite this